期刊文献+

股腘动脉段病变支架内再狭窄的腔内治疗策略分析 被引量:12

Analysis of endovascular treatment strategies on in-stent restenosis of femoropopliteal artery lesions
收藏 分享 导出
摘要 近年来支架植入已被用于治疗复杂的股腘动脉段病变。由于该节段特殊的解剖学部位及生物学应力特点,支架植入后的再狭窄可导致患者缺血的复发,从而需要再次干预,是支架治疗策略的瓶颈。很多学者尝试应用普通球囊扩张、再次支架植入、切割球囊等策略治疗支架内再狭窄,然而结果并不理想。近期减容理念及药物涂层球囊被用于支架内再狭窄的治疗,获得了令人欣喜的结果。同时,使用覆膜支架或药物洗脱支架用于纠正原支架内断裂可得到相对满意的预后。本文总结近年来相关领域的治疗方法及证据,试图为临床治疗股腘动脉段支架内再狭窄提供思路。 Over the last few years, the treatment of complex femoropopliteal lesions led to the increasing use of stents in this challenging anatomical area. Whereas in-stent restenosis remains the Achilles' heel of stenting this segment, and leads to recurrent ischemia and repeated interventions. A majority of endovascular techniques have been evaluated to repair this complication, including plain balloon angioplasty, new stent deployment, cutting balloons but without satisfactory mid- and long-term results. More recently debulking and drug-eluting devices have been applied in femoropopliteal in-stent restenosis with promising results. And relining with a stent graft or drug-eluting stent of femoropopliteal in-stent restenosis can be considered in cases of stent fracture as this strategy has showed relatively optimal outcomes. The aim of this article is to analyze the evidence of those endovascular techniques for the treatment of femoropopliteal in-stent restenosis.
作者 符伟国 岳嘉宁 Fu Weiguo , Yue Jianing.( Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China)
出处 《中华外科杂志》 CAS CSCD 北大核心 2016年第8期586-590,共5页 Chinese Journal of Surgery
关键词 动脉硬化 闭塞性 移植物闭塞 血管 股动脉 腘动脉 Arteriosclerosis obliterans Graft occlusion, vascular Femoral artery Popliteal artery
作者简介 通信作者:符伟国,Email:fu.weiguo@zs—hospital.sh.cn
  • 相关文献

参考文献25

  • 1Tosaka A, Soga Y, Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting [ J ]. J Am Coil Cardiol, 2012,59 ( 1 ) : 16-23. 被引量:1
  • 2Zeller T, Tiefenbacher C, Steinkamp HJ, et al. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT) [ J ]. J Endovasc Ther, 2008,15 (4) :390-398. 被引量:1
  • 3Davaine JM, Az6ma L, Guyomarch B, et al. One-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus ( TASC ) C and D femompopliteal lesions ( the STELLA "STEnting Long de L'ArtSre f6morale superficielle" cohort) [ J ]. Eur J Vase Endovasc Surg, 2012, 44(4) :432-441. 被引量:1
  • 4Geraghty PJ, Mewissen MW, Jaff MR, et al. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease[J]. J Vase Surg, 2013,58(2) :386-395. e4. 被引量:1
  • 5Lammer J, ZeUer T, Hausegger KA, et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions : the randomized VIASTAR trial ( Viabahnendoprosthesis with PROPATEN bioactive surface [VIA ] versus bare nitinol stent in. the treatment of long lesions in superficial femoral artery occlusive disease) [ J]. J Am Coil Cardiol, 2013, 62(15) :1320-1327. 被引量:1
  • 6Dake MD, Ansel GM, Jaff MR, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions : 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies[J]. J Am Coil Cardiol, 2013,61 (24):2417- 2427. 被引量:1
  • 7Katsanos K, Spiliopoulos S, Karunanithy N, et al. Bayesian network meta-analysis of nitinol stents, covered stents, drug- eluting stents, and drug-coated balloons in the femoropopliteal artery[J]. J Vasc Surg, 2014,59(4) :1123-1133. 被引量:1
  • 8Dick P, Sabeti S, Mlekusch W, et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience[ J]. Radiology, 2008,248 ( 1 ) :297-302. 被引量:1
  • 9Stabile E, Virga V, Salemme L, et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis [ J ]. J Am Coil Cardiol, 2012,60(18) :1739-1742. 被引量:1
  • 10Laird JR, Singh GD. Drug-Coated Balloons as the New Standard of Care for Femoropopliteal In-Stent Restenosis : FAIR Assumption? [ J ]. Circulation, 2015,132 (23) :2198-2200. 被引量:1

同被引文献36

引证文献12

二级引证文献25

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈